Your browser doesn't support javascript.
loading
Erratum: METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours.
Glasberg, João; Talans, Aley; Giollo, Thomás Rivelli; Recchimuzzi, Débora Zachello; Neto, João Evangelista Bezerra; Lopez, Rossana Veronica Mendonza; Hoff, Paulo Marcelo Gehm; Riechelmann, Rachel P.
Affiliation
  • Glasberg J; Department of Clinical Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo - FMUSP, São Paulo, Brazil.
  • Talans A; Post Graduate Program, Faculdade de Medicina da Universidade de São Paulo, Brazil.
  • Giollo TR; Department of Medical Radiology, Fleury Group, São Paulo, Brazil.
  • Recchimuzzi DZ; Department of Medical Radiology, Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Neto JEB; Department of Clinical Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo - FMUSP, São Paulo, Brazil.
  • Lopez RVM; Department of Clinical Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo - FMUSP, São Paulo, Brazil.
  • Hoff PMG; Department of Clinical Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo - FMUSP, São Paulo, Brazil.
  • Riechelmann RP; Center for Translational Research in Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo - FMUSP, São Paulo, Brazil.
Ecancermedicalscience ; 16: 1421, 2022.
Article in En | MEDLINE | ID: mdl-36158978

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ecancermedicalscience Year: 2022 Document type: Article Affiliation country: Brazil

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ecancermedicalscience Year: 2022 Document type: Article Affiliation country: Brazil